Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Mar-23 10:00 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 02-Mar-23 | Private Purchase | 66,822 | $7.82 | $522,354.00 | < 1% 19.98M to 20.05M | |
| 02-Mar-23 4:05 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Mar-23 | Private Purchase | 48,867 | $7.94 | $388,082.00 | < 1% 19.93M to 19.98M | |
| 01-Mar-23 4:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Feb-23 | Private Purchase | 815 | $7.97 | $6,495.55 | < 1% 19.93M to 19.93M | |
| 28-Feb-23 4:14 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Feb-23 | Private Purchase | 52,500 | $7.69 | $403,725.00 | < 1% 19.88M to 19.93M | |
| 27-Feb-23 4:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 24-Feb-23 | Private Purchase | 109,118 | $7.64 | $833,552.00 | < 1% 19.77M to 19.88M | |
| 24-Feb-23 4:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Feb-23 | Private Purchase | 51,864 | $7.79 | $403,792.00 | < 1% 19.72M to 19.77M | |
| 23-Feb-23 4:26 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 22-Feb-23 | Private Purchase | 50,941 | $7.83 | $399,016.00 | < 1% 19.67M to 19.72M | |
| 22-Feb-23 4:07 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Feb-23 | Private Purchase | 94,418 | $7.74 | $731,126.00 | < 1% 19.57M to 19.67M | |
| 21-Feb-23 4:07 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Feb-23 | Private Purchase | 63,382 | $7.71 | $488,986.00 | < 1% 19.51M to 19.57M | |
| 17-Feb-23 5:27 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Feb-23 | Private Purchase | 42,682 | $7.90 | $337,043.00 | < 1% 19.47M to 19.51M | |
| 15-Feb-23 4:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Feb-23 | Private Purchase | 6,300 | $7.95 | $50,059.80 | < 1% 19.46M to 19.47M | |
| 14-Feb-23 4:10 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Feb-23 | Private Purchase | 32,474 | $7.97 | $258,837.00 | < 1% 19.43M to 19.46M | |
| 13-Feb-23 4:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Feb-23 | Private Purchase | 11,000 | $7.98 | $87,807.50 | < 1% 19.42M to 19.43M | |
| 02-Feb-23 10:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Feb-23 | Private Purchase | 600 | $7.97 | $4,782.00 | < 1% 19.42M to 19.42M | |
| 27-Jan-23 4:27 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Jan-23 | Private Purchase | 7,886 | $7.99 | $63,006.00 | < 1% 19.41M to 19.42M | |
| 26-Jan-23 4:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jan-23 | Private Purchase | 24,526 | $7.88 | $193,267.00 | < 1% 19.38M to 19.41M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Jan-23 | Purchase | 69,518 | $7.72 | $536,846.00 | < 1% 19.32M to 19.38M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jan-23 | Purchase | 76,046 | $7.64 | $580,839.00 | < 1% 19.24M to 19.32M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Jan-23 | Purchase | 68,953 | $7.41 | $510,611.00 | < 1% 19.17M to 19.24M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 05-Jan-23 | Purchase | 80,035 | $7.38 | $590,554.00 | < 1% 19.09M to 19.17M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 04-Jan-23 | Purchase | 91,892 | $7.80 | $716,877.00 | < 1% 19.0M to 19.09M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-23 | Purchase | 141,646 | $7.50 | $1,063,010.00 | < 1% 18.86M to 19.0M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 30-Dec-22 | Purchase | 99,754 | $7.55 | $753,622.00 | < 1% 18.76M to 18.86M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Dec-22 | Purchase | 84,622 | $7.71 | $652,774.00 | < 1% 18.67M to 18.76M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Dec-22 | Purchase | 71,299 | $7.18 | $511,898.00 | < 1% 18.6M to 18.67M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Dec-22 | Purchase | 145,652 | $7.24 | $1,054,400.00 | < 1% 18.46M to 18.6M | |
| 13-Jan-23 4:19 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Dec-22 | Private Purchase | 100,378 | $7.52 | $754,421.00 | < 1% 18.35M to 18.46M | |
| 31-Oct-22 4:08 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Oct-22 | Grant | 2,551,020 | $9.80 | $25,000,000.00 | 16% 15.8M to 18.35M | |
| 20-Apr-21 5:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion | 13,026,000 | -- | -- | 234% 5.56M to 18.58M | |
| 20-Apr-21 5:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-21 | Purchase | 2,777,780 | $18.00 | $50,000,000.00 | 100% 2.78M to 5.56M | |
| 14-May-19 2:24 PM View: | Gaiam Inc. (GAIA) | 01-May-19 | Disposition (other) | 1,266,460 | $10.58 | $13,399,200.00 | (100%) 1.27M to 0 | 10% |
| 07-Feb-19 4:29 PM View: | Advanced Micro Devices Inc. (AMD) | 05-Feb-19 | Market Sale | 34,906,200 | $23.43 | $817,852,032.00 | (32%) 109.91M to 75.0M | (235%) |
| 07-Feb-19 4:29 PM View: | Advanced Micro Devices Inc. (AMD) | 05-Feb-19 | Exercise (in-the money or at-the-money) | 75,000,000 | $5.98 | $448,500,000.00 | 215% 34.91M to 109.91M | |
| 14-May-19 2:24 PM View: | Gaiam Inc. (GAIA) | 04-Dec-18 | Market Purchase | 15,250 | $12.74 | $194,285.00 | 1% 1.25M to 1.27M | (25%) |
| 01-Aug-18 9:36 PM View: | Advanced Micro Devices Inc. (AMD) | 30-Jul-18 | Market Sale | 22,000,000 | $19.33 | $425,150,016.00 | (17%) 131.91M to 109.91M | (306%) |
| 04-Aug-17 5:29 PM View: | Advanced Micro Devices Inc. (AMD) | 04-Aug-17 | Private Sale | 40,000,000 | $525,600,000.00 | $21,024,000,205,389,824.00 | (23%) 171.91M to 131.91M |